Delivery Order SPE2DB22D2206-SPE2DB25FEU55

Award Date 12/20/24
Potential Completion Date 12/23/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEU55
    Delivery Order

This federal contract award, valued at $1,525.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of the pharmaceutical product QSYMIA 15 MG-92 MG CAPSULE 30S.

The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/21/25, 9:46 AM